Atlas Trials

Macugen for Proliferative Diabetic Retinopathy Study With Extended Dosing (M-PDRS ED)

Clinical trial NCT01486771 · UNKNOWN

Trial details

NCT number
NCT01486771
Sponsor
Valley Retina Institute
Status
UNKNOWN
Phase
Phase 4
Study type
INTERVENTIONAL
Proliferative Diabetic Retinopathy
Start date
2007-11-01
Primary completion
2013-08-01
Enrollment
30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.